Plain-English translation of NCT04995198 on ClinicalTrials.gov ↗ ·
The PROMISE Registry is building a national database of prostate cancer patients to understand how inherited genetic mutations affect the disease and treatment response. Researchers will collect a saliva sample from you to test for genetic variants, along with your medical records and health history. This information will help doctors learn which patients may benefit most from specific treatments and clinical trials based on their genetic profile.
Some people inherit genetic mutations that increase their prostate cancer risk or affect how their cancer responds to treatment. This registry aims to identify patients with these mutations so researchers can better match them with the most effective treatments and help improve survival outcomes.
You likely qualify if…
You likely don't qualify if…
You would provide a saliva sample that gets tested for genetic mutations, and a genetic counselor will discuss any important findings with you. You'll complete a one-time survey about your health and family history, and researchers will request your medical records from your cancer doctors. If you have specific genetic variants, you'll be asked to share updated health information and answer brief surveys every six months for at least 15 years, and you'll receive newsletters about new prostate cancer research and treatment options.
AI-generated summary from trial data · Sep 18, 2026 · Not medical advice
United States